Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-09-03 to 2025-02-11
Current total value of award: $358.92
Description: 8510843504!HEPATITIS A VIRUS V